Gland Pharma remains on track to deliver growth, but at the same time, it continues to be vigilant about not being over dependent on a specific geography, said brokerage Nirmal Bang in a note as it hosted the Gland Pharma management at its Annual Investor Conference to discuss the company’s business outlook. The brokerage house has a Buy rating on …
